Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

A BRIEF REVIEW ON PHARMACOGENOMICS

Pranav Upadhyay, Pranjul Shrivastava*, Rashmi Pandey, Rupali Bharti Sao, Sandip Prasad Tiwari

Faculty of Pharmacy, Kalinga University, Naya Raipur, Chhattisgarh India (492101)

ABSTRACT

Pharmacogenomics is the study of genes and how a drug's effects on a person's response. Pharmacogenomics is a rapidly developing field of medicine that combines the fields of genomics, which studies genes, and pharmacology, which studies drugs, to create safe, effective doses of medication that are specific to each patient's genetic preferences. One of the most important programs in which scientists are creating and learning about the relationship between genes and how the body reacts to drugs is the Human Genome Project. Variations in genetic composition contribute to variations in drug efficacy and can be used to forecast future therapeutic efficacy for a given individual as well as investigate the occurrence of adverse drug reactions. Pharmacogenomics is still in its infancy, despite advances in science and technology. Pharmacogenomics is not widely used, although new methods are continually being tested in clinical settings. Pharmacogenomics will soon make it possible to create specialized medications to treat common health issues like HIV, cancer, asthma, neurological diseases, and cardiovascular disorders.

Keywords: Pharmacogenomics, Gene Sequencing, Genotyping, Phenotyping.


[Full Text Article]